Kishnani, P. S., Attarian, S., Borges, J. L., Bouhour, F., Chien, Y.-H., Choi, Y.-C., … Schoser, B. (2021). Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. In Molecular Genetics and Metabolism (Vol. 132, pp. S57–S57). Elsevier BV. https://doi.org/10.1016/j.ymgme.2020.12.127

Kishnani, Priya S., Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin-Hsiu Chien, Young-Chul Choi, Paula Clemens, et al. “Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients.” In Molecular Genetics and Metabolism, 132:S57–S57. Elsevier BV, 2021. https://doi.org/10.1016/j.ymgme.2020.12.127.

Kishnani PS, Attarian S, Borges JL, Bouhour F, Chien Y-H, Choi Y-C, et al. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. In: Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S57–S57.

Kishnani, Priya S., et al. “Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients.” Molecular Genetics and Metabolism, vol. 132, no. 2, Elsevier BV, 2021, pp. S57–S57. Crossref, doi:10.1016/j.ymgme.2020.12.127.

Kishnani PS, Attarian S, Borges JL, Bouhour F, Chien Y-H, Choi Y-C, Clemens P, Day J, Diaz-Manera J, Erdem-Ozdamar S, Goker-Alpan O, Illarioshkin S, Kostera-Pruszczyk A, Kushlaf H, Ladha S, Mozaffar T, Roberts M, Straub V, Toscano A, van der Ploeg A, Haack KA, Huynh-Ba O, Zhou T, Dimachkie M, Schoser B. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S57–S57.